688139 海爾生物
按盤價 
32.760 +0.260 (+0.800%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.557 | 8.524 | 9.843 | 15.720 | 26.413 |
| 總資產報酬率 ROA (%) | 3.469 | 6.482 | 7.373 | 11.566 | 19.113 |
| 投入資產回報率 ROIC (%) | 4.201 | 7.847 | 8.891 | 13.683 | 22.569 | 邊際利潤分析 |
| 銷售毛利率 (%) | 46.510 | 47.986 | 48.602 | 48.154 | 50.145 |
| 營業利潤率 (%) | 12.028 | 17.594 | 19.221 | 23.592 | 45.226 |
| 息稅前利潤/營業總收入 (%) | 10.675 | 15.531 | 18.017 | 22.872 | 44.640 |
| 淨利潤/營業總收入 (%) | 11.477 | 16.683 | 18.066 | 21.367 | 39.945 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 83.473 | 85.078 | 72.259 | 84.498 | 45.536 |
| 價值變動淨收益/利潤總額(%) | 11.132 | 7.280 | 19.584 | 10.027 | 50.316 |
| 營業外收支淨額/利潤總額(%) | -0.787 | 0.032 | -0.900 | -0.051 | -0.059 | 償債能力分析 |
| 流動比率 (X) | 2.753 | 2.594 | 2.693 | 2.945 | 3.023 |
| 速動比率 (X) | 2.411 | 2.267 | 2.430 | 2.717 | 2.721 |
| 資產負債率 (%) | 18.849 | 20.205 | 19.649 | 24.424 | 25.737 |
| 帶息債務/全部投入資本 (%) | 4.468 | 5.088 | 4.566 | 8.219 | 11.590 |
| 股東權益/帶息債務 (%) | 2,071.626 | 1,804.770 | 2,021.390 | 1,074.899 | 738.859 |
| 股東權益/負債合計 (%) | 407.075 | 373.850 | 389.669 | 299.903 | 287.278 |
| 利息保障倍數 (X) | -8.479 | -7.506 | -17.463 | -32.301 | -79.864 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 57.860 | 40.316 | 27.108 | 16.850 | 20.934 |
| 存貨周轉天數 (天) | 93.348 | 88.304 | 79.620 | 74.708 | 100.831 |
| 備註： | 即時報價更新時間為 04/02/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
